ACTIVE SESSION TAPE Drug Manufacturers - Specialty & Generic $43M Cap Quant: AVOID NEW MONEY

Why Is Talphera, Inc. (TLPH) Stock Down Today?

Updated Nov 16, 2026 2:19 PM ET · Prev Close $0.91

Pro Workspace
Last Session Price
$0.86 -4.98%
-$0.05 vs $0.91 prior close
Intraday Range
$0.83 – $0.89
Open $0.89
Relative Volume
1.20x Avg
171,564 sh
52-Week Range
$0.69 – $1.57
Benchmark Alpha
-3.09% vs SPY
-2.56% vs QQQ
20-Session Trend -19.5%

Session Regime & Catalyst Assessment

68% Signal Conviction
TECHNICAL 68% Driver Weight

Talphera, Inc. Pulling Back 4.98% on 1.20x Relative Volume

Talphera, Inc. (TLPH) is pulling back 4.98% (-$0.05) to $0.86 on 1.20x average session volume. Relative to benchmarks, TLPH is lagging the S&P 500 by -3.09%. 14-day RSI stands at 26.1, keeping momentum in a oversold regime.

NEWS 70% Weight
Talphera Tlph Q3 2026 Earnings Call Transcript

FDA may let Niyad's NEPHRO study close early as enrollment slows sharply.

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($0.86) trades relative to 20-day SMA ($1.04) and 50-day SMA ($1.10).

Volume Confirmation
MODERATE VOLUME (1.20x) Normal
Institutional participation confirms directional price action.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

TLPH lagging the S&P 500 by -3.09%
TLPH Session
-4.98%
$0.86
S&P 500 (SPY)
-1.89%
$740.11
Nasdaq 100 (QQQ)
-2.42%
$663.44
Healthcare (XLV)
-0.38%
$188.14
Alpha vs SPY: -3.09% Alpha vs QQQ: -2.56% Alpha vs XLV: -4.60%

Recent TLPH Catalyst Headlines

Verified Wire
What Talphera TLPH Said on Its Q3 Earnings Call

Talphera Nasdaq Tlph is seeking the U.S. Food and Drug Administration s agreement to end enrollment in its Niyad study by Dec. 31, 2026, after a recent slowdown in recruiting critically ill patients, executives said on t

Yahoo Finance · Nov 13, 2026
Talphera Q3 Earnings Snapshot

TLPH on Thursday reported a loss of 4 million in its third quarter.On a per-share basis, the San Mateo, California-based company said it had a loss of 5 cents.

Yahoo Finance · Nov 12, 2026

1–3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$0.81
Short-term support band
Upper Bound
$0.91
Short-term resistance band
Key Inflection Level
$0.83 (session support)

Monitor volume expansion above 1.5x RVOL around $0.83 (session support) for directional breakout confirmation.

Technical Regime (TLPH)

BEARISH MA TREND
RSI (14)
26.1
Oversold
20-Day SMA
$1.04
Below 20d
50-Day SMA
$1.10
Below 50d
MACD Signal
Bearish
MACD -0.04
ADX (14)
25.4
Strong trend
10d Momentum
-0.15
Soft 10-day momentum

Retail & Crowd Sentiment

Very Bullish
24h Messages
3
2.3x 7d avg
Bullish / Bearish
100.0% / 0.0%
Low buzz
Crowd Discussion Digest

A bullish StockTwits user is looking forward to $TLPH's Q3 2026 report summary, expressing optimism for a resolution by the end of the year.

About Talphera, Inc.

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and Ltx-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Sector
Healthcare
Market Cap
$43M
Employees
13

Get Instant TLPH Catalyst Alerts

Receive an email alert when TLPH triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

TLPH Session & Catalyst FAQ

Why is TLPH stock down today?

Talphera, Inc. (TLPH) is pulling back 4.98% (-$0.05) to $0.86 on 1.20x average session volume. Relative to benchmarks, TLPH is lagging the S&P 500 by -3.09%. 14-day RSI stands at 26.1, keeping momentum in a oversold regime.

Is TLPH stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 1.20x relative volume (moderate participation). Our multi-factor model currently rates TLPH as AVOID NEW MONEY. Review full valuation, quality, and timing signals on the TLPH Buy or Sell Decision Brief →

What is TLPH's intrinsic value and expected trading range?

At $0.86, TLPH's modeled 1-to-3 session range is $0.81 – $0.91, with a key inflection level at $0.83 (session support). Compare current price against multi-year cash flow projections in the TLPH Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for TLPH?

RSI at 26.1 indicates oversold conditions — watch for mean-reversion support. TLPH trades at $0.86 relative to its 20-day SMA ($1.04) and 50-day SMA ($1.10), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs